EP3858830 - Bibliographic data
FORME CRISTALLINE D'UN COMPOSÉ MORPHOLINO QUINAZOLINE, PROCÉDÉ DE PRÉPARATION ASSOCIÉ ET UTILISATION CORRESPONDANTE
| Last update | 05/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Shanghai Yingli Pharmaceutical Co. Ltd. Room 311, Building 4
576 Libing Road
Zhangjiang High-Tech Park
Pudong New Area
Shanghai 201203
Chine
|
|---|---|
| (72) Inventors |
Zusheng XU Room 311, Building 4, No. 576 Libing Road,
Zhangjiang High-Tech Park, Pudong New Area
Shanghai 201203
Chine
Yangtong LOU Room 311, Building 4, No. 576 Libing Road,
Zhangjiang High-Tech Park, Pudong New Area
Shanghai 201203
Chine
|
| (74) Agent |
Mail recipient Dehns 10 Old Bailey
London EC4M 7NG
Royaume-Uni
|
| (21) Request number | EP19864074.0 |
|---|---|
| (22) Request date | 12/09/2019 |
| (11) Publication number | EP3858830 |
|---|---|
| Publication date | 16/11/2022 |
| (54) Title of the invention | FORME CRISTALLINE D'UN COMPOSÉ MORPHOLINO QUINAZOLINE, PROCÉDÉ DE PRÉPARATION ASSOCIÉ ET UTILISATION CORRESPONDANTE |
|---|---|
| (51) International classification | C07D 401/14, A61P 37/00, A61P 35/00, A61P 29/00, A61K 31/517 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201811131702 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 5 -
Amount: 100 € -
Due date 02/10/2023
Surtax: 5 - Amount: 20 € - Due date 03/04/2024 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 16/11/2022 Entrée en période de grâce du brevet d'invention - Legal date 03/10/2023 Déchéance du brevet d'invention après période de grâce - Legal date 02/10/2023 |